| Ytd | -35.26% | |
| 1y | -24.32% |
| Open | 2.25 | Prev Close | 2.27 | Low | 2.22 | High | 2.34 | Mkt Cap | 36.45M |
| Vol | 249.70K | Avg Vol | 712.75K | EPS | -0.47 | P/E | N/A | Forward P/E | -2.90 |
| Beta | 1.51 | Short Ratio | 3.25 | Inst. Own | 21.39% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 06-20 | 50-d Avg | 2.39 | 200-d Avg | 3.27 | 1yr Est | 10.44 |
Gainers Can Fite Biopharma (AMEX:CANF) stock moved upwards by 52.0% to $4.52 during Wednesday's
Grace Therapeutics (NASDAQ:GRCE) reported quarterly losses of $(0.06) per share which beat the analy